Kogan FY26 presentation: $1B sales milestone, stock falls 15%

Kogan Group posted FY26 gross sales of $1.04B (+12.0% YoY) and adjusted EBITDA of $41.8M (+13.8% YoY) with an 8.2% margin, but shares dropped ~15% (to ~$3.82; -15.3% from $4.51) after investors questioned turnaround progress at Mighty Ape. Kogan.com accelerated, with revenue up 16.2% to $425.2M and adjusted EBITDA up 22.4% to $45.1M, while Mighty Ape revenue fell 30% to $85.6M and still ended FY26 with an adjusted EBITDA loss of $3.3M despite a first profitable 4Q (+$0.4M). Management reaffirmed the medium-term target for group adjusted EBITDA margins to rise toward 12% (from 8.2%), supported by AI-driven efficiency gains and capital returns (FY26 dividends 16.0c/share, +14% YoY; $20.2M buybacks).

Analysis

The market is signaling that the core issue is not today’s earnings power but durability. Kogan’s operating leverage is real, yet the equity is still being priced like a clean compounding platform even though a material portion of group quality depends on a turnaround asset that can swing the consolidated growth rate and suppress the multiple. In other words, the business is getting credit for mix shift and AI-led efficiency, but not enough discount for how fragile that margin story is if promotion intensity or consumer demand softens.

Second-order, the gross margin gains are easier to achieve on a cleared-inventory base than on a normalized replenishment cycle, so the next 1-2 quarters are the real test. If the NZ unit stops being a drag, the stock can rally hard; if not, every incremental dollar of core growth is likely to be capped by skepticism about sustainability. Competitively, this progress pressures smaller online retailers more than the incumbents: well-capitalized omnichannel players can defend price and service, while Kogan’s high platform mix makes it vulnerable to any take-rate or traffic normalization.

The contrarian view is that the selloff may be overdone in the short run because balance-sheet risk is low and capital returns provide a floor. But on a 6-12 month horizon, the valuation still looks demanding for a company with execution risk embedded in one subsidiary and a consumer backdrop that can reverse operating leverage quickly. The key falsifier is sustained group revenue growth above mid-single digits while the turnaround business turns cash-positive; without that, the market is likely to keep compressing the multiple.

Key Decisions for Investors

• Short KGGNF on strength or via any liquid borrow available; thesis is multiple compression as the market stops paying for headline margin improvement without group-level quality. Risk/reward improves if it reclaims the prior $4.50 area on no fundamental follow-through; stop if group revenue and EBITDA both accelerate for two consecutive updates.
• Pair trade: long JBH.AX / short KGGNF for 1-3 months. JBH has cleaner earnings visibility and less turnaround noise, while Kogan’s valuation still embeds a successful restructuring. Falsify if KGGNF shows a durable improvement in group revenue and the NZ drag disappears.
• Do not chase the dip for a long-only entry until the next trading update confirms Mighty Ape remains EBITDA-positive and inventory normalization does not reverse gross margin. This is a watchlist item, not a conviction long, until the market gets proof rather than narrative.
• Set an alert on KGGNF around a sustained move back above $4.50 or a renewed break below the recent post-results low. Above $4.50, the short thesis weakens materially; below the low, the market is likely pricing in a longer restructuring runway.